Overjet

Overjet is a dental artificial intelligence company founded in 2018 by a team of PhDs and dentists from MIT and Harvard. Headquartered in Palo Alto, California, it is led by co-founder and CEO Dr. Wardah Inam, PhD, with clinical leadership including a Chief Dental Officer and a Clinical Director. Its mission is to improve oral health for all and make dentistry more patient-centric and evidence-based.

Overjet's platform integrates with dental imaging and practice management systems to detect, outline, and quantify oral disease in dental radiographs. The company holds multiple FDA clearances—described as a dental-industry first—covering bone-level measurement, caries detection, calculus identification, and image enhancement. In clinical testing, its bone-level measurements reportedly differed from a dentist consensus by an average of only about 0.3mm. The technology serves both clinical practice (helping dentists diagnose and communicate with patients) and the payer side (assisting with insurance claim review).

Overjet has raised capital across multiple rounds, including a $42.5 million Series B (reaching a reported $425 million valuation) and a later $53 million round described as the largest single investment in dental AI history, with Insight Partners among its investors. It works with large dental organizations and DSOs—notably Dental Care Alliance, which supports 400+ affiliated practices and 900+ dentists across 24 states.

As an AI-driven company at the intersection of dentistry, imaging, and insurance, Overjet is directly positioned to be affected by innovations in medical AI, diagnostic imaging, and regulatory technology.